Rekombinanter IFNG (Emapalumab Biosimilar) Antikörper
Reaktivität: Human
FACS, SPR, Func, ELISA, BLI
Wirt: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target Alle IFNG (Emapalumab Biosimilar) Produkte
- IFNG (Emapalumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
-
Human
- Expressionssystem
- CHO Cells
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser IFNG (Emapalumab Biosimilar) Antikörper ist unkonjugiert
- Applikation
- Flow Cytometry (FACS), Surface Plasmon Resonance (SPR), Functional Studies (Func), ELISA, Bio-Layer Interferometry (BLI)
- Verwendungszweck
- Anti-IFNg Reference Antibody (emapalumab)
- Sequenz
- EVQLLESGGG LVQPGGSLRL SCAASGFTFS SYAMSWVRQA PGKGLEWVSA ISGSGGSTYY ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCAKDG SSGWYVPHWF DPWGQGTLVT VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKR VEPKSCDKTH TCPPCPAPEL LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS REEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK,NFMLTQPHSV SESPGKTVTI SCTRSSGSIA SNYVQWYQQR PGSSPTTVIY EDNQRPSGVP DRFSGSIDSS SNSASLTISG LKTEDEADYY CQSYDGSNRW MFGGGTKLTV LGQPKAAPSV TLFPPSSEEL QANKATLVCL ISDFYPGAVT VAWKADSSPV KAGVETTTPS KQSNNKYAAS SYLSLTPEQW KSHRSYSCQV THEGSTVEKT VAPTECS
- Produktmerkmale
- Anti-IFNg Reference Antibody (emapalumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hulambda. It has a predicted MW of 145.5 kDa.
- Reinheit
- >95 %
- Isotyp
- IgG1
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Therapeutic Agents by Target and Mechanism: IFNγ inhibitors
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- 1 mg/mL
- Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
- Lagerung
- 4 °C,-80 °C
- Informationen zur Lagerung
- +4°C,-80°C
-
- Target
- IFNG (Emapalumab Biosimilar)
- Abstract
- IFNG (Emapalumab Biosimilar) Produkte
- Substanzklasse
- Biosimilar
- Molekulargewicht
- 145.5 kDa
- UniProt
- P01579
-
Sie sind hier:
